NanoViricides
NNVC
$1.10
Share price
-0.90%
Change (1 day)
-17.29%
Change (1 year)
Categories
EPS for NanoViricides (NNVC)
EPS in 2023 (TTM): -$0.59
According to NanoViricides's latest financial reports the company's current EPS (TTM) is -$0.59. In 2022 the company made an earnings per share (EPS) of -$0.60 an increase over its 2021 EPS that were of -$0.77.
EPS history for NanoViricides from 2006 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.59 | -1.67% |
| 2022 | -$0.60 | -22.08% |
| 2021 | -$0.77 | -52.47% |
| 2020 | -$1.62 | -22.12% |
| 2019 | -$2.08 | -5.88% |
| 2018 | -$2.21 | -30.94% |
| 2017 | -$3.20 | -20% |
| 2016 | -$4.00 | 111.85% |
| 2015 | -$1.89 | -27.38% |
| 2014 | -$2.60 | -55.17% |
| 2013 | -$5.80 | 56.76% |
| 2012 | -$3.70 | 15.63% |
| 2011 | -$3.20 | -8.57% |
| 2010 | -$3.50 | 66.67% |
| 2009 | -$2.10 | 15.38% |
| 2008 | -$1.82 | -21.67% |
| 2007 | -$2.32 | -17.02% |
| 2006 | -$2.80 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $4.39 | -844.07% | 🇺🇸 USA |
 Merck MRK | $1.82 | -408.76% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $3.97 | -772.88% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $3.50 | -693.34% | 🇬🇧 UK |
 Novavax NVAX | -$7.19 | 1,118.64% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | -$1.25 | 111.86% | 🇺🇸 USA |